MCMedicalCodingSoftware
J2503

J2503: Injection, pegaptanib sodium, 0.3 mg

HCPCSTerminatedBETOS O1E

J2503 is a HCPCS Level II code for injection, pegaptanib sodium, 0.3 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on September 30, 2025 and is not valid on new claims.

This code has been terminated

CMS terminated J2503 on September 30, 2025. It stays in the file as history: a claim you are auditing from before that date may legitimately carry it, but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q4-Oct. This states Medicare’s position on the code, not on your particular claim.

The CMS record for J2503

Long descriptor
Injection, pegaptanib sodium, 0.3 mg

The official wording. This is what the code means.

Short descriptor
Pegaptanib sodium injection

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2006

When CMS introduced the code.

Terminated
September 30, 2025

When CMS retired it.

BETOS
O1E

Berenson-Eggers Type of Service: CMS's own analytic grouping.

Pricing indicator
51: Other

Drugs.

Codes adjacent to J2503

HCPCS has no hierarchy: related items simply sit next to each other in the numbering. If J2503 is not quite right, the correct code is very often within a few positions of it.

  • J2460Injection, oxytetracycline hcl, up to 50 mg
  • J2468Injection, palonosetron hydrochloride (posfrea), 25 micrograms
  • J2469Injection, palonosetron hcl, 25 mcg
  • J2470Injection, pantoprazole sodium, 40 mg
  • J2471Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg
  • J2472Injection, pantoprazole sodium in sodium chloride (baxter), 40 mg
  • J2501Injection, paricalcitol, 1 mcg
  • J2502Injection, pasireotide long acting, 1 mg
  • J2504Injection, pegademase bovine, 25 iuterminated
  • J2505Injection, pegfilgrastim, 6 mgterminated
  • J2506Injection, pegfilgrastim, excludes biosimilar, 0.5 mg
  • J2507Injection, pegloticase, 1 mg
  • J2508Injection, pegunigalsidase alfa-iwxj, 1 mg
  • J2510Injection, penicillin g procaine, aqueous, up to 600,000 units
  • J2513Injection, pentastarch, 10% solution, 100 mlterminated
  • J2515Injection, pentobarbital sodium, per 50 mg
HCPCS Level II2026Q4-Oct· effective October 1, 2026